| Screening/enrollment | FET cycle | Post FET | Pregnancy confirmation OB scan | Pregnancy follow-up | |
---|---|---|---|---|---|---|
 |  |  | 9–14 days post FET | 6–8 weeks | Each trimester and delivery | |
 |  | Modified natural | Programmed |  |  |  |
Informed consent | X | Â | Â | Â | Â | Â |
Eligibility determination | X | Â | Â | Â | Â | Â |
Demographics | X | Â | Â | Â | Â | Â |
Medical, reproductive, and obstetric history | X | Â | Â | Â | Â | Â |
Medication reconciliation | X | X | X | X | X | X |
Vital signs | X | Â | Â | Â | X | X |
Physical exam | X | Â | Â | Â | Â | Â |
PAP smear will be recommended to be done with gynecologist if not done according to ACOG guidelines | X | Â | Â | Â | Â | Â |
Ultrasound (transvaginal while at study site) | Â | X | X | Â | X | X |
Estradiol medication self-administration (programmed cycle only) | Â | Â | X | X | X | Â |
hCG self-administration (medication to trigger ovulation) | Â | X | Â | Â | Â | Â |
Progesterone medication self-administration | Â | X | X | X | X | Â |
Embryo transfer | Â | X | X | Â | Â | Â |
Questionnaires | X | Â | Â | X | Â | Â |
Randomization | X | Â | Â | Â | Â | Â |
Adverse event monitoring | Â | X | X | X | X | X |
Medical record release | Â | Â | Â | Â | X | Â |
Pregnancy data collection | Â | Â | Â | Â | Â | X |
Delivery data collection | Â | Â | Â | Â | Â | X |
Neonatal data collection | Â | Â | Â | Â | Â | X |
Blood and urine samples for banking at study site (baseline scan of first cycle, 6–8 weeks pregnancy visit) |  | X | X |  | X |  |
Blood draw(s) for hormone levels used in cycle monitoring | Â | X | X | Â | Â | Â |
Optional specimen collection at study site | Â | Â | Â | Â | Â | X |